FABP4 antibody (N-Term)

Catalog No. ABIN336086

This anti-FABP4 antibody is a Mouse Monoclonal antibody detecting FABP4 in WB and EIA. Suitable for Human and Mouse.

Quick Overview for FABP4 antibody (N-Term) (ABIN336086)

Target: FABP4 (Fatty Acid Binding Protein 4, Adipocyte (FABP4))

Reactivity: Human, Mouse

Host: Mouse

Clonality: Monoclonal

Conjugate: This FABP4 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Clone: 3F4

Product Details anti-FABP4 Antibody

Binding Specificity: AA 1-132, N-Term

Specificity: The antibody recognizes human and mouse FABP4. Other species not tested.

Characteristics: Synonyms: A-FABP, Adipocyte lipid-binding protein, Fatty acid-binding protein 4

Purification: Protein-G affinity chromatography

Immunogen: Recombinant human FABP4 (1-132 aa) purified from E. coli

Isotype: IgG1

Application Details

Application Notes: ELISA. Western blot (1: 500 - 2,000).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.4, containing 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for up to two weeks or (in aliquots) at -20 °C forlonger. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Expiry Date: 12 months

Target Details for FABP4

Target: FABP4 (Fatty Acid Binding Protein 4, Adipocyte (FABP4))

Alternative Name: FABP4

Background: FABP4 (Fatty acid binding protein 4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. FABP4 is thought to regulate fatty acid uptake, release, and storage in adipocytes and participates in systemic glucose homeostasis and in macrophage responses in atherosclerosis. Blocking this protein either through genetic engineering or drugs has the possibility of treating heart disease, diabetes, asthma, obesity, and fatty liver disease.Synonyms: A-FABP, Adipocyte lipid-binding protein, Fatty acid-binding protein 4

Gene ID: 2167

UniProt: P15090

Pathways: Brown Fat Cell Differentiation